EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Vitreoretinal Disease: a Critical Review on Current Technological Perspectives and Innovative drug-delivery Strategies

Krishnapriya M, Aswin Damodaran, Sharon K Joseph, Vishal Kumar, Gopal S Pillai, Sreeja C Nair

Therapeutic Delivery · 2023

DOI: 10.4155/tde-2022-0070 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Delivery, 2023. Verfasst von Krishnapriya M und 5 weiteren Autor:innen. Beteiligte Einrichtung: Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, Kerala, 682041, India. Hauptthemen laut MEDLINE: Eye Diseases, Biological Products. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 152 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim: To review the state of the art aspects and contemporary innovative drug delivery strategies, for the treatment of vitreoretinal diseases, their mechanism of action through ocular routes and their future perspectives. Materials & methods: Scientific databases such as PubMed, Science Direct, Google scholar were used to obtain 156 papers for review. The keywords searched were vitreoretinal diseases; ocular barriers; intravitreal injections; nanotechnology; biopharmaceuticals. Results & conclusion: The review explored the various routes which can be used to facilitate drug delivery adopting novel strategies, the pharmacokinetic aspects of novel drug-delivery strategies in treating posterior segment eye diseases and current research. Therefore, this review drives focus into the same and underlines their implications to the healthcare sector in making necessary interventions. Eye diseases that affect the major part of the eye can create eyesight loss in patients. Even though medicines are now available, there is a need to drive the existing techniques further. These can be done by the use of small sized particles in the treatment, which are easy to reach the site wherever healing is required. Natural medicines and treatment can also benefit people. In this paper, we discuss treatment approaches on these factors and their importance in curing people with eye diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eye DiseasesBiological ProductsHumansDrug Delivery SystemsEyeNanotechnology

Stichwörter der Autor:innen

biopharmaceuticalsintravitreal injectionsnanotechnologyocular barriersvitreoretinal diseases

Substanzen

Biological Products

Autor:innen und Institutionen

  • Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, Kerala, 682041, India.
  • Department of Opthalmology, Professor & Head of Department, Amrita Institute of Medical Science, AIMS, Kochi, Kerala, 682041, India.

Zitieren

APA

M, K., Damodaran, A., Joseph, S. K., Kumar, V., Pillai, G. S., & Nair, S. C. (2023). Vitreoretinal Disease: a Critical Review on Current Technological Perspectives and Innovative drug-delivery Strategies. Therapeutic Delivery. https://doi.org/10.4155/tde-2022-0070

Vancouver

M K, Damodaran A, Joseph SK, Kumar V, Pillai GS, Nair SC. Vitreoretinal Disease: a Critical Review on Current Technological Perspectives and Innovative drug-delivery Strategies. Therapeutic Delivery. 2023. doi:10.4155/tde-2022-0070

BibTeX
@article{M2023,
  author = {M, Krishnapriya and Damodaran, Aswin and Joseph, Sharon K and Kumar, Vishal and Pillai, Gopal S and Nair, Sreeja C},
  title = {Vitreoretinal Disease: a Critical Review on Current Technological Perspectives and Innovative drug-delivery Strategies},
  journal = {Therapeutic Delivery},
  year = {2023},
  doi = {10.4155/tde-2022-0070}
}
Kostenlos starten →